Cargando…

SARS-CoV-2 Infection in Patients with Lung Cancer: Current Clinical Context()

Detalles Bibliográficos
Autores principales:	Isea de la Viña, Jesus, Ortega-Granados, Ana Laura, Alcázar-Navarrete, Bernardino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SEPAR. Published by Elsevier España, S.L.U. 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521908/ http://dx.doi.org/10.1016/j.arbr.2020.03.020

Ejemplares similares

Situación clínica de infección por SARS-CoV-2 en pacientes con carcinoma broncogénico: contexto actual
por: Isea de la Viña, Jesús, et al.
Publicado: (2020)

Lung cancer patients on the waiting list in the midst of the COVID-19 crisis: what do we do now?()
por: Isea de la Viña, Jesus, et al.
Publicado: (2020)

Pacientes con carcinoma broncogénico en lista de espera en plena crisis del COVID-19: ¿y ahora qué hacemos?
por: Isea de la Viña, Jesus, et al.
Publicado: (2020)

Management and follow up of respiratory patients in the post-Covid-19 era: Are we ready yet?()
por: Alcázar-Navarrete, Bernardino, et al.
Publicado: (2020)

Putting some context to the aerosolization debate around SARS-CoV-2
por: Peters, A., et al.
Publicado: (2020)

Omicron variant in the current SARS-CoV-2 pandemic
por: Nasiri, Kaveh, et al.
Publicado: (2022)

SARS-CoV-2 and dentistry
por: Ortega, Karem L., et al.
Publicado: (2020)

Proposed practice guidelines for burn centres in the context of the SARS-CoV-2 pandemic
por: Zieliński, Michał, et al.
Publicado: (2020)

Research during the SARS-CoV-2 pandemic()
por: Muñoz de Nova, José Luis, et al.
Publicado: (2021)

SARS-CoV-2 Vaccination in the Context of Ongoing HIV Cure-Related Research Studies
por: Peluso, Michael J., et al.
Publicado: (2021)

Altered severity of the current SARS-CoV-2 in the Kurdistan region of Iraq
por: Hussein, Safin, et al.
Publicado: (2020)

Proteomic profiling of lung diffusion impairment in the recovery stage of SARS‐CoV‐2–induced ARDS
por: García‐Hidalgo, María C., et al.
Publicado: (2022)

SARS-CoV-2 and the myths about vaccination()
por: Travezaño-Cabrera, Aaron, et al.
Publicado: (2021)

SARS‐CoV‐2 infection in lung transplant recipients induces circulating exosomes with SARS‐CoV‐2 spike protein S2
por: Bansal, Sandhya, et al.
Publicado: (2021)

Impaired lung regeneration after SARS‐CoV‐2 infection
por: Shao, Hongxia, et al.
Publicado: (2020)

Lung ultrasonography unmasking the asymptomatic SARS-CoV-2 carrier
por: Tung-Chen, Yale, et al.
Publicado: (2021)

Lung ultrasonography unmasking the asymptomatic SARS-CoV-2 carrier
por: Tung-Chen, Yale, et al.
Publicado: (2021)

Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays
por: Moran, Angelica, et al.
Publicado: (2020)

Opioid agonist treatment during SARS-CoV2 & extended lockdown: Adaptations & challenges in the Indian context
por: Ghosh, Abhishek, et al.
Publicado: (2020)

Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection
por: Kong, Qi, et al.
Publicado: (2020)

The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
por: Xia, Yong, et al.
Publicado: (2020)

Slit-lamp evaluation during SARS-CoV-2 pandemic: safety first!
por: Ruiz-Lozano, Raul E., et al.
Publicado: (2020)

Comments on “CSF-Confirmed SARS-CoV-2 Acute Encephalitis”: SARS-CoV-2-Associated Encephalitis Is Autoimmune Rather Than Infectious
por: Finsterer, Josef, et al.
Publicado: (2022)

Living with COVID-19: could SARS-CoV-2 infection present a ping-pong effect?
por: LAGHI, ALESSANDRO, et al.
Publicado: (2021)

SARS-CoV-2 in cardiomyocytes
por: Finsterer, Josef
Publicado: (2021)

Pharmacotherapeutics of SARS-CoV-2
por: Gupta, Harish, et al.
Publicado: (2022)

SARS-CoV-2 antibody response eight months after vaccination with mRNA vaccines. Influence of prior SARS-CoV-2 exposure
por: García-Cruces-Méndez, Jesús Fernando, et al.
Publicado: (2022)

Is SARS-CoV-2 responsible for relapses of Parkinson’s disease?
por: Scorza, Fulvio A., et al.
Publicado: (2021)

Captopril alleviates lung inflammation in SARS-CoV-2-infected hypertensive mice
por: Gao, Wen-Cong, et al.
Publicado: (2021)

Pathophysiology of SARS-CoV-2 associated ischemic stroke
por: Finsterer, Josef, et al.
Publicado: (2022)

Comment on: “Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence”
por: Mazza, Mario Gennaro, et al.
Publicado: (2022)

A stark difference in the profiles of defective viral transcripts between SARS-CoV-2 and SARS-CoV
por: Xie, Dongying, et al.
Publicado: (2021)

SARS CoV-2 genetic jump to a new SARS CoV-3 pandemic: Let’s be prepared
por: Kelleni, Mina T.
Publicado: (2023)

Indication of glucocorticoid pulses for patients with SARS-CoV-2 infection()
por: Blasco Patiño, Felipe, et al.
Publicado: (2021)

Pathophysiology of SARS-CoV-2-associated ischemic stroke is variegated
por: Scorza, Fulvio A., et al.
Publicado: (2021)

Immune response in SARS-CoV-2
por: Aguilar-Shea, Antonio Luis, et al.
Publicado: (2020)

SARS‐CoV‐2 immunogenicity at the crossroads
por: Karamloo, Fariba, et al.
Publicado: (2020)

Transmission routes of SARS-CoV-2
por: Patel, Jay
Publicado: (2020)

SARS-CoV-2 and EBV coinfection()
por: García-Martínez, Francisco Javier, et al.
Publicado: (2020)

Peptide Targets to SARS-CoV-2
por: Mandal, Santi M.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0gvk16tpn27aaleishqnhqgvt8